J. Goldman & Co’s Guardian Pharmacy Services GRDN Stock Holding History

J. Goldman & Co’s Portfolio GRDN Stock Details GRDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.32M	Sell	79,219 -80,353	-50%	-$3.11M	0.09%	269
2026 Q1	$6.01M	Buy	159,572 +58,435	+58%	+$1.91M	0.17%	158
2025 Q4	$3.04M	Sell	101,137 -555,723	-85%	-$15.7M	0.08%	267
2025 Q3	$17.2M	Sell	656,860 -1,127,243	-63%	-$26.9M	0.43%	69
2025 Q2	$38M	Buy	1,784,103 +960,032	+116%	+$21.7M	0.91%	16
2025 Q1	$17.5M	Buy	824,071 +61,724	+8%	+$1.27M	0.43%	71
2024 Q4	$15.4M	Buy	762,347 +11,263	+1%	+$233K	0.4%	72
2024 Q3	$12.6M	Buy	+751,084	New	+$12.7M	0.35%	86

Other funds holding GRDN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

VCM

Valiant Capital Management San Francisco, California $2.48B AUM 57.08% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

J. Goldman & Co's GRDN Position: Q2 2026 in Review

J. Goldman & Co reduced its Guardian Pharmacy Services (GRDN) stake by 50% in Q2 2026, selling an estimated $3.11M and leaving 79,219 shares worth $3.32M. The position accounts for 0.09% of the portfolio, ranked #269.

J. Goldman & Co first reported a position in GRDN in Q3 2024 and has held it in 8 quarters since. The position peaked at $38M in Q2 2025. 173 funds tracked by Wall St. Rank hold GRDN as of Q2 2026.

J. Goldman & Co held 79,219 shares of Guardian Pharmacy Services worth $3.32M as of Q2 2026.
J. Goldman & Co sold 80,353 Guardian Pharmacy Services shares in Q2 2026, an estimated $3.11M.
Guardian Pharmacy Services made up 0.09% of J. Goldman & Co's portfolio in Q2 2026, its #269 holding.
J. Goldman & Co first reported a position in Guardian Pharmacy Services in Q3 2024 and has held it in 8 quarters since.
J. Goldman & Co's Guardian Pharmacy Services position peaked at $38M in Q2 2025.
173 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q2 2026.

Based on J. Goldman & Co's 13F filing for Q2 2026, filed 14 Aug 2026.